Diagnostics and the 100-day mission: why preparedness cannot wait

Caitlin R. Thompson; Emily R. Adams; Tom E. Fletcher

doi:10.1093/trstmh/trag052

Diagnostics and the 100-day mission: why preparedness cannot wait

University of Oxford

Research output: Contribution to journal › Comment/debate

Abstract

The 2025 International Panel for Pandemic Surveillance Report and the G7 100-day mission emphasise rapid deployment of diagnostics, but preparatory infrastructure is vital to achieve this goal. Drawing on lateral flow development and haemorrhagic fever case studies, we highlight the requirement for pre-established diagnostic building blocks, including monoclonal antibodies, antigens, biological reference materials and regulatory pathways. Persistent funding imbalances and inequitable global investment threaten timely outbreak response. Sustained preparedness investment, strengthened biobanking and equitable access frameworks will ensure that diagnostics can be delivered within meaningful response timelines.

Original language	English
Pages (from-to)	898-900
Number of pages	3
Journal	Transactions of the Royal Society of Tropical Medicine and Hygiene
Volume	120
Issue number	8
Early online date	1 May 2026
DOIs	https://doi.org/10.1093/trstmh/trag052
Publication status	Published - 1 Aug 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

diagnostics
global health equity
lateral flow tests
pandemic preparedness

Access to Document

10.1093/trstmh/trag052Licence: CC BY-NC

trag052Final published version, 245 KBLicence: CC BY-NC

Cite this

@article{ac8540c55b1e4b7bb6056ee560ada24e,

title = "Diagnostics and the 100-day mission: why preparedness cannot wait",

abstract = "The 2025 International Panel for Pandemic Surveillance Report and the G7 100-day mission emphasise rapid deployment of diagnostics, but preparatory infrastructure is vital to achieve this goal. Drawing on lateral flow development and haemorrhagic fever case studies, we highlight the requirement for pre-established diagnostic building blocks, including monoclonal antibodies, antigens, biological reference materials and regulatory pathways. Persistent funding imbalances and inequitable global investment threaten timely outbreak response. Sustained preparedness investment, strengthened biobanking and equitable access frameworks will ensure that diagnostics can be delivered within meaningful response timelines.",

keywords = "diagnostics, global health equity, lateral flow tests, pandemic preparedness",

author = "Thompson, \{Caitlin R.\} and Adams, \{Emily R.\} and Fletcher, \{Tom E.\}",

year = "2026",

month = aug,

day = "1",

doi = "10.1093/trstmh/trag052",

language = "English",

volume = "120",

pages = "898--900",

journal = "Transactions of the Royal Society of Tropical Medicine and Hygiene",

issn = "0035-9203",

publisher = "Oxford University Press",

number = "8",

}

TY - JOUR

T1 - Diagnostics and the 100-day mission: why preparedness cannot wait

AU - Thompson, Caitlin R.

AU - Adams, Emily R.

AU - Fletcher, Tom E.

PY - 2026/8/1

Y1 - 2026/8/1

N2 - The 2025 International Panel for Pandemic Surveillance Report and the G7 100-day mission emphasise rapid deployment of diagnostics, but preparatory infrastructure is vital to achieve this goal. Drawing on lateral flow development and haemorrhagic fever case studies, we highlight the requirement for pre-established diagnostic building blocks, including monoclonal antibodies, antigens, biological reference materials and regulatory pathways. Persistent funding imbalances and inequitable global investment threaten timely outbreak response. Sustained preparedness investment, strengthened biobanking and equitable access frameworks will ensure that diagnostics can be delivered within meaningful response timelines.

AB - The 2025 International Panel for Pandemic Surveillance Report and the G7 100-day mission emphasise rapid deployment of diagnostics, but preparatory infrastructure is vital to achieve this goal. Drawing on lateral flow development and haemorrhagic fever case studies, we highlight the requirement for pre-established diagnostic building blocks, including monoclonal antibodies, antigens, biological reference materials and regulatory pathways. Persistent funding imbalances and inequitable global investment threaten timely outbreak response. Sustained preparedness investment, strengthened biobanking and equitable access frameworks will ensure that diagnostics can be delivered within meaningful response timelines.

KW - diagnostics

KW - global health equity

KW - lateral flow tests

KW - pandemic preparedness

U2 - 10.1093/trstmh/trag052

DO - 10.1093/trstmh/trag052

M3 - Comment/debate

C2 - 42065140

AN - SCOPUS:105046639430

SN - 0035-9203

VL - 120

SP - 898

EP - 900

JO - Transactions of the Royal Society of Tropical Medicine and Hygiene

JF - Transactions of the Royal Society of Tropical Medicine and Hygiene

IS - 8

ER -

Diagnostics and the 100-day mission: why preparedness cannot wait

Abstract

UN SDGs

Keywords

Access to Document

Fingerprint

Cite this